Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ June 5, 2023 ] Amgen continues to target mid-December deadline for Horizon deal close Los Angeles Biotech News
  • [ June 5, 2023 ] Akero’s NASH candidate reduces liver fat in patients taking a GLP-1 Los Angeles Biotech News
  • [ June 5, 2023 ] Pharmaceutical Visual Inspector Technician – MedisourceRx – Los Alamitos, CA Los Angeles Biotech Jobs
  • [ June 5, 2023 ] Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023 Los Angeles Biotech News
  • [ June 5, 2023 ] Bansk Group-Backed Arcadia Consumer Health Acquires Avrio Health Los Angeles Biotech News
HomeLos Angeles Biotech NewsSTAT+: Supreme Court rules against Amgen in closely watched case over scope of patent claims

STAT+: Supreme Court rules against Amgen in closely watched case over scope of patent claims

May 18, 2023 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on STAT+: Supreme Court rules against Amgen in closely watched case over scope of patent claims
U.S. Supreme Court has ruled against Amgen in a patent case that had the entire pharmaceutical on edge.

Click to view original post

Previous

Profile: Life Sciences graduating senior and future medical student, Arjun Verma

Next

Outside Sales Rep | BioPioneer | Los Angeles

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered